FIELD: chemistry.
SUBSTANCE: present invention relates to the pharmaceutical industry, specifically to heat-inactivated Lactobacillus rhamnosus conjugated with a polysaccharide polymer binder. Method for producing heat-inactivated Lactobacillus rhamnosus RHT-3201 (Lactobacillus rhamnosus KCTC 10833BP), conjugated with polysaccharide polymer binder. Heat-inactivated Lactobacillus rhamnosus RHT-3201 (Lactobacillus rhamnosus KCTC 10833BP), conjugated with a polysaccharide polymer binder. Pharmaceutical composition for the treatment of atopic diseases, wherein the composition contains, as an active ingredient, heat-inactivated Lactobacillus rhamnosus RHT-3201 (Lactobacillus rhamnosus KCTC 10833BP), conjugated with a polysaccharide polymer binder. Use of heat-inactivated Lactobacillus rhamnosus RHT-3201 (Lactobacillus rhamnosus KCTC 10833BP), conjugated with a polysaccharide polymer binder to prepare an agent for treating atopic dermatitis. Method of treating atopy. Composition of the product to reduce the severity of atopic dermatitis. Use of heat-inactivated Lactobacillus rhamnosus RHT-3201 (Lactobacillus rhamnosus KCTC 10833BP), conjugated with a polysaccharide polymer binder to produce a product to reduce the severity of atopic dermatitis. Method for treating or reducing the severity of atopic disease.
EFFECT: above-described agents have a higher therapeutic effect in atopic diseases.
15 cl, 26 dwg, 13 tbl
| Title |
Year |
Author |
Number |
| STRAIN LACTOBACILLUS GASSERI KBL697 AND ITS USE |
2019 |
- Ko, Vu Ri
- Li, Dzhun Chkhul
- Pak, Khe In
- Nam, Te Vuk
- Ko, Kvan Pe
- Kim, Vun Ki
- An, De Khi
- Kim, In Su
- Li, Dzhin Vu
- Kim, Khe Dzhin
|
RU2798872C2 |
| LACTOBACILLUS CRISPATUS KBL693 STRAIN AND ITS APPLICATION |
2019 |
- Ko, Vu Ri
- Li, Dzhun Chkhul
- Nam, Te Vuk
- Ko, Kvan Pe
- Yu, Khen Dzhu
- Yun, So En
- Son, Sok Chkhon
|
RU2791561C2 |
| USE OF PROBIOTIC BACTERIUM LYSATE FOR IMPROVEMENT AND/OR RESTORATION OF BARRIER FUNCTION OF SKIN |
2013 |
- O'Nejl Ketrin
- Makbejn Endryu
|
RU2656152C2 |
| STRAIN OF LACTIC BACTERIUM FOR TREATING INFLAMMATION IN INFLAMMATORY INTESTINAL DISEASE, COMPONENT EFFECTIVE IN TREATING ULCER, METHOD OF TREATING INFLAMMATION IN INFLAMMATORY INTESTINAL DISEASE, PRODUCT (VERSIONS) AND COMPOSITION (VERSIONS) |
2006 |
|
RU2378370C2 |
| NON-REPLICATING PROBIOTIC MICROORGANISMS PROTECTING AGAINST INFECTIONS OF UPPER AIRWAY |
2011 |
- Pti Valeri
- Garsia-Rodenas Klara Lyusiya
- Yulita Monik
- Mersene Annik
- Priu Gyunole
- Nyutten Sofi
|
RU2589706C2 |
| NON-REPLICATING PROBIOTIC MICROORGANISMS PROTECTING CHILDREN FROM GASTROINTESTINAL INFECTIONS |
2011 |
- Pti Valeri
- Garsia-Rodenas Klara Ljusija
- Julita Monik
- Mersen'E Annik
- Priu Gjunole
- Njutten Sofi
|
RU2568830C2 |
| COMPOSITION COMPRISING PROBIOTIC BACTERIA FOR USE IN TREATING IMMUNE DISORDERS |
2011 |
- Mogna Giovanni
- Strozzi Gian Paolo
- Mogna Luca
- Drago Lorenzo
|
RU2712751C2 |
| DOMESTIC ANIMAL FODDERS CONTAINING PROBIOTIC MICROORGANISMS |
2011 |
- Mersene Annik
- Priu Gjunole
- Njutten Sofi
|
RU2580881C2 |
| NOVEL LACTIC ACID BACTERIA AND COMPOSITIONS CONTAINING SAME |
2012 |
- Lang Christine
- Raab Andreas
- Golletz Patrick
|
RU2683225C2 |
| EXTRUDED NON-REPLICATING PROBIOTIC MICROORGANISMS AND APPLICATION THEREOF FOR HEALTH |
2011 |
- Mersene Annik
- Vermej Antuan
- Demon Odri
- Priu Gjunole
|
RU2583692C2 |
